220 related articles for article (PubMed ID: 22348878)
1. Genome-wide studies of the transcriptional regulation by p53.
Li M; He Y; Feng X; Huang J
Biochim Biophys Acta; 2012 Jul; 1819(7):684-7. PubMed ID: 22348878
[TBL] [Abstract][Full Text] [Related]
2. Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis.
Nikulenkov F; Spinnler C; Li H; Tonelli C; Shi Y; Turunen M; Kivioja T; Ignatiev I; Kel A; Taipale J; Selivanova G
Cell Death Differ; 2012 Dec; 19(12):1992-2002. PubMed ID: 22790872
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth.
Zhu J; Sammons MA; Donahue G; Dou Z; Vedadi M; Getlik M; Barsyte-Lovejoy D; Al-awar R; Katona BW; Shilatifard A; Huang J; Hua X; Arrowsmith CH; Berger SL
Nature; 2015 Sep; 525(7568):206-11. PubMed ID: 26331536
[TBL] [Abstract][Full Text] [Related]
4. p53 binding sites in normal and cancer cells are characterized by distinct chromatin context.
Bao F; LoVerso PR; Fisk JN; Zhurkin VB; Cui F
Cell Cycle; 2017; 16(21):2073-2085. PubMed ID: 28820292
[TBL] [Abstract][Full Text] [Related]
5. TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity.
Sammons MA; Zhu J; Drake AM; Berger SL
Genome Res; 2015 Feb; 25(2):179-88. PubMed ID: 25391375
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.
Pfister NT; Prives C
Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27836911
[TBL] [Abstract][Full Text] [Related]
7. One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor.
Böhlig L; Rother K
J Biomed Biotechnol; 2011; 2011():464916. PubMed ID: 21436991
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and epigenetic regulation of the p53 tumor suppressor gene.
Saldaña-Meyer R; Recillas-Targa F
Epigenetics; 2011 Sep; 6(9):1068-77. PubMed ID: 21814038
[TBL] [Abstract][Full Text] [Related]
9. Detection of p53 protein transcriptional activity by chromatin immunoprecipitation.
Yang-Hartwich Y; Romanoff E; Bingham J; Alvero AB; Mor G
Methods Mol Biol; 2015; 1219():87-93. PubMed ID: 25308264
[TBL] [Abstract][Full Text] [Related]
10. Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforming-growth-factor-beta-mediated transcription repression.
Wilkinson DS; Tsai WW; Schumacher MA; Barton MC
Mol Cell Biol; 2008 Mar; 28(6):1988-98. PubMed ID: 18212064
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of p53 under hypoxic conditions.
Hammond EM; Mandell DJ; Salim A; Krieg AJ; Johnson TM; Shirazi HA; Attardi LD; Giaccia AJ
Mol Cell Biol; 2006 May; 26(9):3492-504. PubMed ID: 16611991
[TBL] [Abstract][Full Text] [Related]
12. p53 in the DNA-Damage-Repair Process.
Williams AB; Schumacher B
Cold Spring Harb Perspect Med; 2016 May; 6(5):. PubMed ID: 27048304
[TBL] [Abstract][Full Text] [Related]
13. Expanding the p53 regulatory network: LncRNAs take up the challenge.
Grossi E; Sánchez Y; Huarte M
Biochim Biophys Acta; 2016 Jan; 1859(1):200-8. PubMed ID: 26196323
[TBL] [Abstract][Full Text] [Related]
14. Functions of p53 in metabolism and invasion.
Vousden KH
Biochem Soc Trans; 2009 Jun; 37(Pt 3):511-7. PubMed ID: 19442244
[TBL] [Abstract][Full Text] [Related]
15. p53 isoforms - a conspiracy to kidnap p53 tumor suppressor activity?
Marcel V; Hainaut P
Cell Mol Life Sci; 2009 Feb; 66(3):391-406. PubMed ID: 18854945
[TBL] [Abstract][Full Text] [Related]
16. Interactions of mutant p53 with DNA: guilt by association.
Kim E; Deppert W
Oncogene; 2007 Apr; 26(15):2185-90. PubMed ID: 17401427
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53: one name, many proteins.
Freed-Pastor WA; Prives C
Genes Dev; 2012 Jun; 26(12):1268-86. PubMed ID: 22713868
[TBL] [Abstract][Full Text] [Related]
18. The Crusade against Mutant p53: Does the COMPASS Point to the Holy Grail?
Abraham CG; Espinosa JM
Cancer Cell; 2015 Oct; 28(4):407-408. PubMed ID: 26461087
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways.
Yu CL; Driggers P; Barrera-Hernandez G; Nunez SB; Segars JH; Cheng S
Biochem Biophys Res Commun; 1997 Oct; 239(2):617-20. PubMed ID: 9344880
[TBL] [Abstract][Full Text] [Related]
20. p53: a guide to apoptosis.
Meulmeester E; Jochemsen AG
Curr Cancer Drug Targets; 2008 Mar; 8(2):87-97. PubMed ID: 18336191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
